Ekaterina Pazukhina
Overview
Explore the profile of Ekaterina Pazukhina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahvash Mohammadi S, Rumyantsev M, Abdeeva E, Baimukhambetova D, Bobkova P, El-Taravi Y, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002280
Background: The COVID-19 pandemic has led to widespread long-term complications, known as post-COVID conditions (PCC), particularly affecting vulnerable populations such as cancer patients. This study aims to predict the incidence...
2.
Krivonosov M, Pazukhina E, Zaikin A, Viozzi F, Lazzareschi I, Manca L, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685931
: Respiratory viral infections (RVIs) exhibit seasonal patterns influenced by biological, ecological, and climatic factors. Weather variables such as temperature, humidity, and wind impact the transmission of droplet-borne viruses, potentially...
3.
Pazukhina E, Garcia-Gallo E, Reyes L, Kildal A, Jassat W, Dryden M, et al.
BMJ Glob Health
. 2024 Oct;
9(10).
PMID: 39433402
Introduction: A proportion of people develop Long Covid after acute COVID-19, but with most studies concentrated in high-income countries (HICs), the global burden is largely unknown. Our study aims to...
4.
Demidova A, Drewitz K, Kimkool P, Banjanin N, Barzylovich V, Botjes E, et al.
Allergy
. 2024 Mar;
79(4):977-989.
PMID: 38433402
Background: IgE-mediated food allergy (FA) is a global health concern with substantial individual and societal implications. While diverse intervention strategies have been researched, inconsistencies in reported outcomes limit evaluations of...
5.
Pazukhina E, Rumyantsev M, Baimukhambetova D, Bondarenko E, Markina N, El-Taravi Y, et al.
BMC Med
. 2024 Feb;
22(1):48.
PMID: 38302974
Background: Long-term health outcomes in children and young people (CYP) after COVID-19 infection are not well understood and studies with control groups exposed to other infections are lacking. This study...
6.
Channon-Wells S, Vito O, McArdle A, Seaby E, Patel H, Shah P, et al.
Lancet Rheumatol
. 2023 Mar;
5(4):e184-e199.
PMID: 36855438
Background: Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently...
7.
Buonsenso D, Pazukhina E, Gentili C, Vetrugno L, Morello R, Zona M, et al.
J Clin Med
. 2022 Nov;
11(22).
PMID: 36431250
Previous studies assessing the prevalence of COVID-19 sequelae in children have included either a small number of children or a short follow-up period, or have only focused on hospitalized children....
8.
Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al.
BMC Med
. 2022 Jul;
20(1):244.
PMID: 35794549
Background: Previous studies assessing the prevalence of COVID-19 sequelae in adults and children were performed in the absence of an agreed definition. We investigated prevalence of post-COVID-19 condition (PCC) (WHO...
9.
Buonsenso D, Munblit D, Pazukhina E, Ricchiuto A, Sinatti D, Zona M, et al.
Front Pediatr
. 2022 May;
10:834875.
PMID: 35529336
Background: Emerging evidence shows that both adults and children may develop post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this study is to characterise and compare long-term post-SARS-CoV-2 infection...